首页|克拉霉素联合替硝唑治疗小儿HP相关性胃炎的临床研究

克拉霉素联合替硝唑治疗小儿HP相关性胃炎的临床研究

扫码查看
目的 分析克拉霉素联合替硝唑治疗小儿HP(Helicobacter pylori,幽门螺杆菌)相关性胃炎的临床效果.方法 选取100例幽门螺杆菌相关性胃炎患儿为研究对象.对照组进行50 mg/(g?d)阿莫西林联合20 mg/(g?d)甲硝唑治疗,2次/天.对照组进行克拉霉素联合替硝唑治疗,20 mg/(g?d)克拉霉素,20 mg/(g?d)替硝唑,2次/天.比较分析实验组与对照组患儿临床疗效与HP根除率和不良反应的发生情况.结果 经过对应的治疗后,实验组中,45例患儿根治.对照组中,35例患儿根治.可得,对照组幽门螺杆菌根治率为90.0%显著高于对照组70.0%,具有统计学意义(P<0.05).对照组中,15例有效,25例患儿显效.实验组中,显效患儿为32例,有效为16例.可得,实验组治疗有效率为96.0%显著高于对照组有效率为80.0%,具有统计学意义(P<0.05).对照组中,3例出现并发症.实验组中,2例出现并发症,2组并发症发生率分别为6.0%与4.0%,差异无统计学意义.结论 克拉霉素联合替硝唑治疗小儿HP相关性胃炎临床疗效较为理想,安全性高,能够显著改善患儿相关临床症状.
Clinical study of clarithromycin combined with tinidazole in the treatment of HP associated gastritis in children
Objective To study and analyze the clinical effect of clarithromycin combined with tinidazole in the treatment of HP associated gastritis in children. Abstract 100 children with HP associated gastritis were selected as the subjects. The control group was treated with 50 mg/(g?d) amoxicillin combined with 20 mg/(g?d) metronidazole, twice a day. The control group was treated with clarithromycin combined with tinidazole, 20 mg/(g?d) clarithromycin, 20 mg/(g?d) tinidazole, twice a day. The clinical efficacy, the rate of HP eradication and adverse reactions of the experimental group and the control group were compared and analyzed. Results After the corresponding treatment, 45 patients in the experimental group were radical cured. In the control group, 35 cases were radical cured. The radical cured rate of HP of the control group (90.0%) was significantly higher than that (70.0 %) in control group, which was statistically significant (P<0.05). In the control group, 15 cases were valid, and 25 cases were better effective. In the experimental group, 32 cases were better effective, and 16 cases were valid. The effective rate of the experimental group was 96.0%, which was significantly higher than that (80.0%) of the control group with statistical difference (P<0.05). In the control group, 3 cases occurred complications, in the experimental group, 2 cases occurred complications, and the incidence of complications in two groups was 6.0% and 4.0% respectively. There was no significant difference between two groups. Conclusion Clarithromycin combined with tinidazole in the treatment of pediatric HP associated gastritis has better efficacy, high safety, could significantly improve the clinical symptoms of patients, with clinical significance.

clarithromycintinidazolehelicobacter pyloriassociated gastritisclinical effect

余建华、姚燕平

展开 >

常山县人民医院 儿科,浙江 衢州 324200

克拉霉素 替硝唑 幽门螺杆菌 相关性胃炎 临床效果

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(10)
  • 9
  • 6